Skip to content
DraconiticResearch
Search Sources API
181,713 studies31 sourcesUpdated 33 min ago
PreprintAll rights reservedmedRxiv

Comparative Efficacy of Vancomycin and Fidaxomicin Regimens for the Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

  • C. Prosty1
  • G. Butler-Laporte
  • J. Brophy
  • E. Bortolussi-Courval
  • C. Frenette
  • V. Loo
  • S. Hota
  • Y. Longtin
  • L. Kong
  • M. Muller
  • T. Steiner
  • L. Valiquette
9 more authors
  • N. Daneman
  • P. Daley
  • C. Nott
  • D. R. MacFadden
  • C. Kandel
  • Y. Chen
  • S. Perez- Patrigeon
  • T. C. Lee
  • E. McDonald
  1. 1McGill
Read full textPDFDOICite

Related

  1. Case Commentary: Emergence of clinically relevant fidaxomicin-resistant Clostridioides difficile strains
    Kevin W. Garey, Julian G. Hurdle
    Antimicrobial Agents and ChemotherapyPeer-reviewedCC BY 4.0Full text1 citedInfectious diseasePMC
  2. Faecalibacterium prausnitzii EXL01 Strain for the prevention of multiple-recurrent Clostridioides difficile Infection
    Nicolas Benech, Perle Guarino-Vignon, Paul Mclellan +31
    GastroenterologyPeer-reviewedCC BY-NC-NDInfectious diseaseHAL
  3. Global prevalence of vancomycin-resistant Enterococcus in patients with haematological malignancies: a systematic review and meta-analysis
    Fatimah Suliman Mohammad Aljebaly
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCEurope PMCPMC
  4. Continuous infusion versus intermittent infusion of vancomycin: a systematic review and meta-analysis with a focus on nephrotoxicity, target attainment, and clinical outcomes
    Xunuo Ma, Leiting Xu, Jianfei Zhang +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMCPMC
  5. Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes of Vancomycin and β-Lactam Antibiotics in Adults With Augmented Renal Clearance: A Systematic Review.
    Mohammed Asiri, Sarah Alharbi, Mashail Alharbi +1
    CureusPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{prosty2026comparative,
  title = {{Comparative Efficacy of Vancomycin and Fidaxomicin Regimens for the Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials}},
  author = {C. Prosty and G. Butler-Laporte and J. Brophy and E. Bortolussi-Courval and C. Frenette and V. Loo and S. Hota and Y. Longtin and L. Kong and M. Muller and T. Steiner and L. Valiquette and N. Daneman and P. Daley and C. Nott and D. R. MacFadden and C. Kandel and Y. Chen and S. Perez- Patrigeon and T. C. Lee and E. McDonald},
  howpublished = {medRxiv},
  year = {2026},
  month = jul,
  doi = {10.64898/2026.07.14.26358112},
  url = {https://www.medrxiv.org/content/10.64898/2026.07.14.26358112v2},
}
RIS
TY  - UNPB
TI  - Comparative Efficacy of Vancomycin and Fidaxomicin Regimens for the Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
AU  - C. Prosty
AU  - G. Butler-Laporte
AU  - J. Brophy
AU  - E. Bortolussi-Courval
AU  - C. Frenette
AU  - V. Loo
AU  - S. Hota
AU  - Y. Longtin
AU  - L. Kong
AU  - M. Muller
AU  - T. Steiner
AU  - L. Valiquette
AU  - N. Daneman
AU  - P. Daley
AU  - C. Nott
AU  - D. R. MacFadden
AU  - C. Kandel
AU  - Y. Chen
AU  - S. Perez- Patrigeon
AU  - T. C. Lee
AU  - E. McDonald
PY  - 2026
DA  - 2026/07/14
PB  - medRxiv
DO  - 10.64898/2026.07.14.26358112
UR  - https://www.medrxiv.org/content/10.64898/2026.07.14.26358112v2
ER  -